Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: A systematic review and meta-analysis

Osteoarthritis and Cartilage

Volumn 19, Issue 12, 2011, Pages 1396-1404

  Hoch, J M ^a   Mattacola, C G ^a   Medina McKeon, J M ^a   Howard, J S ^a   Lattermann, C ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Biomarkers; Degenerative joint disease; Kellgren Lawrence; Radiography

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN;

ARTICLE; CARTILAGE OLIGOMERIC MATRIX PROTEIN BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

ADULT; AGED; BIOLOGICAL MARKERS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HUMANS; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SEVERITY OF ILLNESS INDEX;

EID: 82955163131     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.09.005     Document Type: Article

References (38)

1. Garnero P., Delmas P.D. Biomarkers in osteoarthritis. Curr Opin Rheumatol 2003, 15:641-646.
2. Tseng S., Reddi A.H., Di Cesare P.E. Cartilage oligomeric matrix protein (COMP): a biomarker of arthritis. Biomark Insights 2009, 4:33-44.
3. Fernandes F.A., Pucinelli M.L.C., da Silva N.P., Feldman D. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation. Scand J Rheumatol 2007, 36(3):211-215.
4. Clark A.G., Jordan J.M., Vilim V., Renner J.B., Dragomir A.D., Luta G., et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum 1999, 42(11):2356-2364.
5. Palmieri-Smith R.M., Thomas A.C. A neuromuscular mechanism of posttraumatic osteoarthritis associated with ACL injury. Exerc Sport Sci Rev 2009, 37(3):147-153.
6. Vilim V., Vytasek R., Olejarova M., Machacek S., Gatterova J., Prochazka B., et al. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis. Osteoarthritis Cartilage 2001, 9(7):612-618.
7. Andersson M.L.E., Thorstensson C.A., Roos E.M., Petersson I.F., Heinegayrd D., Saxne T. Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis. BMC 2006, 7(98). 10.1186/1471-2474-7-98.
8. Bruyere O., Collette J.C., Ethgen O. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. J Rheumatol 2002, 30:1043-1050.
9. Garnero P., Piperno M., Gineyts E., Christgau S., Delmas P.D., Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001, 60(6):619-626.
10. Wislowska M., Jablonska B. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis. Clin Rheumatol 2005, 2:278-284.
11. Senolt L., Braun M., Olejarova M., Forejtova S., Gatterova J., Pavelka K. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein. Ann Rheum Dis 2005, 64(6):886-890.
12. Wakitani S., Nawata M., Kawaguchi A., Okabe T., Takaoka K., Tsuchiya T., et al. Serum keratan sulfate is a promising marker of early articular cartilage breakdown. Rheumatology 2007, 46(11):1652-1656.
13. Pavelka K., Forejtova S., Olejarova M., Gatterova J., Senolt L., Spacek P., et al. Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthritis Cartilage 2004, 12(4):277-283.
14. Cibere J., Zhang H., Garnero P., Poole A.R., Lobanok T., Saxne T., et al. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum 2009, 60(5):1372-1380.
15. Bauer D.C., Hunter D.J., Abramson S.B., Attur M., Corr M., Felson D., et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 2006, 14(8):723-727.
16. Otterness I.G., Swindell A.C., Zimmerer R.O., Poole A.R., Ionescu M., Weiner E. An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage 2000, 8(3):180-185.
17. Hedbom E., Antonsson P., Hjerpe A., Aeschlimann D., Paulsson M., Rosa-Pimentel E., et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992, 267(9):6132-6136.
18. Muller G., Michel A., Altenburg E. COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage. Connect Tissue Res 1998, 39(4):233-244.
19. Neidhart M., Hauser N., Paulsson M., DiCesare P.E., Michel B.A., Hauselmann H.J. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997, 36(11):1151-1160.
20. DiCesare P., Hauser N., Lehman D., Pasumarti S., Paulsson M. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 1994, 354(2):237-240.
21. Recklies A.D., Baillargeon L., White C. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. Arthritis Rheum 1998, 41(6):997-1006.
22. Bleasel J.F., Poole A.R., Heinegard D., Saxne T., Holderbaum D., Ionescu M., et al. Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutation. Arthritis Rheum 1999, 42(1):39-45.
23. Jordan J.M., Luta G., Stabler M., Renner J.B., Dragomir A.D., Vilim V., et al. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project. Arthritis Rheum 2003, 48(3):675-681.
24. Borenstein M., Hedges L., Higgins J., Rothstein H. Introduction to Meta-analysis 2009, John Wiley & Sons, Ltd., West Sussex, UK.
25. Orwin R.G. A Fail-Safe N for effect size in meta-analysis. J Educ Stat 1983, 8(2):157-159.
26. Munn J., Sullivan S.J., Schneiders A.G. Evidence of sensorimotor deficits in functional ankle instability: a systematic review with meta-analysis. J Sci Sports Med 2010, 13(1):2-12.
27. Downs S., Black N. The feasibility of creating a check list for the assessment of methodological quality of both randomised and non-randomised trials. J Epidemiol Community Health 1998, 52(6):377-384.
28. Dragomir A.D., Kraus V.B., Renner J.B., Luta G., Clark A., Vilim V., et al. Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology. Osteoarthritis Cartilage 2002, 10(9):687-691.
29. Schiphof D., Boers M., Bierma-Zeinstra S.M.A. Differences in descriptions of Kellgren and Lawrence grades of knee osteoarthritis. Ann Rheum Dis 2008, 67:1034-1036.
30. Hedges L.V., Olkin I. Statistical Methods for Meta-analysis 1985, Academic Press Inc.
31. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbuam Assoc., Hillsdale, NJ. 2nd edn.
32. Centre for Evidence Based Medicine Levels of evidence and grades of recommendation [cited 2010 May 15]; Available from. http://www.cebm.net/index.aspx%3Fo%3D1025.
33. Mundermann A., King K.B., Smith R.L., Andriacchi T.P. Change in serum COMP concentration due to ambulatory load is not related to knee OA status. J Orthop Res 2009, 27(11):1408-1413.
34. Nuesch E., Trelle S., Reichenbach S., Rutjes A., Tschannen B., Altman D., et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010, 341:c3515. 10.1136/bmj.c3515.
35. Oiestad B.E., Engebretsen L., Storheim K., Risberg M.A. Knee osteoarthritis after anterior cruciate ligament injury: a systematic review. Am J Sports Med 2009, 37(7):1434-1443.
36. Stabler T., Fang F., Jordan J., Vilim V., Kraus V.B. A comparison of methods for measuring cartilage oligomeric matrix protein (COMP) in human subjects with knee OA. Osteoarthritis Cartilage 2007, 15(Suppl C). C81-C82.
37. Vilim V., Voburka Z., Vytasek R., Senolt L., Tchetverikov I., Kraus V.B., et al. Monoclonal antibodies to human cartilage oligomeric matrix protein: epitope mapping and characterization of sandwich ELISA. Clin Chim Acta 2003, 328:59-69.
38. Reed G.F., Lynn F., Meade B.D. Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol 2002, 9(6):1235-1239.